The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties
- 9 February 2007
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 25 (8), 1464-1469
- https://doi.org/10.1016/j.vaccine.2006.10.033
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological preventionBMC Bioinformatics, 2005
- New Adjuvants for Parenteral and Mucosal VaccinesTherapies, 2005
- Toll-like receptors in innate immunityInternational Immunology, 2004
- Immunological Foundations to the Quest for New Vaccine AdjuvantsBioDrugs, 2004
- Role of Toll-Like Receptors in Pathogen RecognitionClinical Microbiology Reviews, 2003
- Regulation of Dendritic Cell Function Through Toll-like ReceptorsCurrent Molecular Medicine, 2003
- Toll-Like ReceptorsAnnual Review of Immunology, 2003
- New approaches towards the identification of antibiotic and vaccine targets in Streptococcus pneumoniaeEMBO Reports, 2002
- Identification of Potential Vaccine and Drug Target Candidates by Expressed Sequence Tag Analysis and Immunoscreening ofOnchocerca volvulusLarval cDNA LibrariesInfection and Immunity, 2000
- Molecular targets and cancer therapeutics: discovery, development and clinical validationDrug Resistance Updates, 2000